BIB

Ultra Nasdaq Biotechnology

Investment Objective

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

Documents & Downloads

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB Market Price -1.13% -6.90% -17.54% 8.57% -3.39% -0.78% 0.46% -3.13% 14.45% 04/07/2010
BIB NAV -1.08% -7.11% -17.59% 8.57% -3.48% -0.81% 0.42% -3.14% 14.44% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.14%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 3/24/2025
  • NAV
    $54.31
  • NAV Change
    $+1.31 up caret
  • Market Price
    $54.20
  • Market Price Change
    $+1.30 up caret
  • Trading Volume (M)
    8,024
  • 30-Day Median Bid Ask Spread
    0.30%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Expense Ratio
    0.95%
  • Gross Expense Ratio
    1.14%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 3/24/2025
  • NAV
    $54.31
  • NAV Change
    $+1.31 up caret
  • Market Price
    $54.20
  • Market Price Change
    $+1.30 up caret
  • Trading Volume (M)
    8,024
  • 30-Day Median Bid Ask Spread
    0.30%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2025. Without the fee waiver performance would likely be lower.

Exposures

Index as of 12/31/2024

Holdings

as of 3/24/2025

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
6.34% VRTX VERTEX PHARMACEUTICALS INC -- $3,858,519.60 7,540 2931034
6.07% AMGN AMGEN INC -- $3,691,764.34 11,743 2023607
5.55% GILD GILEAD SCIENCES INC -- $3,377,894.04 31,646 2369174
5.27% REGN REGENERON PHARMACEUTICALS -- $3,205,850.00 4,850 2730190
3.20% AZN ASTRAZENECA PLC-SPONS ADR -- $1,946,270.21 26,269 2989044
2.79% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,697,688.00 5,840 B00FWN1
1.54% BIIB BIOGEN INC -- $934,984.80 6,603 2455965
1.44% ARGX ARGENX SE - ADR -- $877,879.80 1,444 BDVLM39
1.19% SNY SANOFI-ADR -- $725,020.59 12,963 2964557
1.13% SMMT SUMMIT THERAPEUTICS INC -- $688,521.82 33,278 BMTVQS7
1.08% RPRX ROYALTY PHARMA PLC- CL A -- $659,745.00 19,548 BMVP7Y0
1.07% INSM INSMED INC -- $648,137.70 8,165 2614487
1.07% UTHR UNITED THERAPEUTICS CORP -- $648,036.36 2,026 2430412
1.04% ITCI INTRA-CELLULAR THERAPIES INC -- $631,764.90 4,797 BHCB0P4
1.03% ILMN ILLUMINA INC -- $628,990.92 7,146 2613990
1.02% BMRN BIOMARIN PHARMACEUTICAL INC -- $619,545.94 8,606 2437071
0.98% MRNA MODERNA INC -- $594,728.85 17,405 BGSXTS3
0.90% INCY INCYTE CORP -- $548,069.40 8,730 2471950
0.85% NBIX NEUROCRINE BIOSCIENCES INC -- $519,968.80 4,498 2623911
0.82% VTRS VIATRIS INC -- $500,795.70 53,849 BMWS3X9
0.79% ONC BEIGENE LTD-ADR -- $478,041.60 1,888 BYYWPW6
0.78% EXEL EXELIXIS INC -- $476,252.72 12,626 2576941
0.75% ASND ASCENDIS PHARMA A/S - ADR -- $457,604.76 2,724 BV9G6B8
0.75% MEDP MEDPACE HOLDINGS INC -- $454,230.66 1,374 BDCBC61
0.74% BNTX BIONTECH SE-ADR -- $451,672.32 4,488 BK6H543
0.73% TEM TEMPUS AI INC -- $444,919.00 7,541 BSLSJJ0
0.71% PCVX VAXCYTE INC -- $428,820.38 5,809 BKPVGH6
0.64% JAZZ JAZZ PHARMACEUTICALS PLC -- $389,134.80 2,740 B4Q5ZN4
0.58% HALO HALOZYME THERAPEUTICS INC -- $355,695.12 5,556 2975098
0.57% ROIV ROIVANT SCIENCES LTD -- $348,606.87 32,189 BMW4NZ9
0.57% MDGL MADRIGAL PHARMACEUTICALS INC -- $345,014.40 996 BD59BS7
0.55% SRPT SAREPTA THERAPEUTICS INC -- $334,096.41 4,377 B8DPDT7
0.54% RVMD REVOLUTION MEDICINES INC -- $329,944.58 8,387 BL71K91
0.53% BBIO BRIDGEBIO PHARMA INC -- $319,347.60 8,580 BK1KWG8
0.47% AXSM AXSOME THERAPEUTICS INC -- $284,174.00 2,200 BYZR4X4
0.45% BPMC BLUEPRINT MEDICINES CORP -- $274,663.41 2,883 BWY52P3
0.43% GH GUARDANT HEALTH INC -- $260,248.32 5,568 BFXC911
0.42% ALKS ALKERMES PLC -- $255,219.44 7,336 B3P6D26
0.42% KRYS KRYSTAL BIOTECH INC -- $252,577.56 1,299 BD6JX35
0.41% CYTK CYTOKINETICS INC -- $248,776.94 5,342 BBBSBJ5
0.39% IONS IONIS PHARMACEUTICALS INC -- $239,869.95 7,171 BDJ0LS6
0.39% VRNA VERONA PHARMA PLC - ADR -- $237,402.90 3,555 BYWPZK5
0.38% NUVL NUVALENT INC-A -- $230,262.90 2,985 BMVBZD3
0.36% ADMA ADMA BIOLOGICS INC -- $216,692.48 10,664 B9NSBM2
0.33% PTCT PTC THERAPEUTICS INC -- $202,912.74 3,558 B17VCN9
0.30% RNA AVIDITY BIOSCIENCES INC -- $180,585.90 5,423 BMWHPY1
0.30% ACLX ARCELLX INC -- $179,677.92 2,479 BPCJ1Q2
0.27% CRSP CRISPR THERAPEUTICS AG -- $164,896.78 3,869 BDHF4K6
0.27% RARE ULTRAGENYX PHARMACEUTICAL IN -- $164,249.28 4,173 BJ62Z18
0.27% SWTX SPRINGWORKS THERAPEUTICS INC -- $163,963.80 3,380 BGMGM89
0.27% AKRO AKERO THERAPEUTICS INC -- $161,927.36 3,592 BK7Y2V9
0.26% ALVO ALVOTECH SA -- $157,216.00 13,600 BPNTJ34
0.25% RYTM RHYTHM PHARMACEUTICALS INC -- $153,209.44 2,852 BF2YWG4
0.25% MRUS MERUS NV -- $152,016.09 3,117 BZBY005
0.25% CRNX CRINETICS PHARMACEUTICALS IN -- $150,876.12 4,198 BDD19F8
0.24% IMVT IMMUNOVANT INC -- $148,968.72 7,663 BJRFSB7
0.24% PTGX PROTAGONIST THERAPEUTICS INC -- $145,455.57 2,769 BDCBCD8
0.24% SRRK SCHOLAR ROCK HOLDING CORP -- $144,402.51 4,271 BFZQ0L8
0.23% APLS APELLIS PHARMACEUTICALS INC -- $137,360.12 5,662 BYTQ6X1
0.22% LEGN LEGEND BIOTECH CORP-ADR -- $133,876.05 3,685 BMX9K07
0.21% ACAD ACADIA PHARMACEUTICALS INC -- $129,638.52 7,524 2713317
0.21% XENE XENON PHARMACEUTICALS INC -- $125,861.85 3,453 BRJ3GY4
0.20% AMRX AMNEAL PHARMACEUTICALS INC -- $124,308.87 13,983 BFNF1D6
0.20% RXRX RECURSION PHARMACEUTICALS-A -- $121,011.38 17,822 BM9FJ13
0.20% TWST TWIST BIOSCIENCE CORP -- $120,933.54 2,691 BGKG6G7
0.20% FOLD AMICUS THERAPEUTICS INC -- $120,443.40 13,860 B19FQ48
0.20% -- NEWAMSTERDAM PHARMA CO NV -- $118,896.00 4,954 BP8JSP4
0.19% VCYT VERACYTE INC -- $116,590.56 3,516 BFTWZY0
0.18% VCEL VERICEL CORP -- $108,056.76 2,254 BSBMN89
0.17% MIRM MIRUM PHARMACEUTICALS INC -- $103,961.22 2,211 BJDX8Y8
0.17% ZLAB ZAI LAB LTD-ADR -- $100,625.07 2,821 BD9GVY0
0.16% EWTX EDGEWISE THERAPEUTICS INC -- $99,836.64 4,272 BKY5JZ8
0.16% KYMR KYMERA THERAPEUTICS INC -- $98,741.00 2,930 BMPRZV5
0.16% NVCR NOVOCURE LTD -- $98,069.24 4,958 BYSS4X4
0.16% CGON CG ONCOLOGY INC -- $97,972.02 3,434 BRBCSP4
0.16% LGND LIGAND PHARMACEUTICALS -- $97,041.23 869 2501578
0.16% DNLI DENALI THERAPEUTICS INC -- $96,692.76 6,551 BD2B4V0
0.15% IBRX IMMUNITYBIO INC -- $93,876.15 32,939 BNSP0B8
0.15% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $92,536.08 5,352 BKX9VD3
0.15% BEAM BEAM THERAPEUTICS INC -- $90,637.75 3,775 BK6L288
0.15% TARS TARSUS PHARMACEUTICALS INC -- $90,635.16 1,731 BMH5RL1
0.15% HRMY HARMONY BIOSCIENCES HOLDINGS -- $88,578.88 2,587 BKSGZN7
0.14% ARWR ARROWHEAD PHARMACEUTICALS IN -- $88,164.00 5,688 BYQBFJ8
0.14% TVTX TRAVERE THERAPEUTICS INC -- $85,223.87 4,003 BLFGJD5
0.14% JANX JANUX THERAPEUTICS INC -- $84,618.84 2,666 BMFX8Y7
0.14% IRON DISC MEDICINE INC -- $83,718.30 1,559 BMGJZJ8
0.14% AGIO AGIOS PHARMACEUTICALS INC -- $83,521.35 2,585 BCBVTX1
0.14% APGE APOGEE THERAPEUTICS INC -- $82,946.04 2,031 BM9HHL5
0.14% SUPN SUPERNUS PHARMACEUTICALS INC -- $82,338.60 2,518 B72ZBG4
0.13% VERA VERA THERAPEUTICS INC -- $78,083.40 2,876 BL55460
0.13% DVAX DYNAVAX TECHNOLOGIES CORP -- $77,462.48 5,597 BRJZSK0
0.12% BCRX BIOCRYST PHARMACEUTICALS INC -- $75,887.35 9,427 2100362
0.12% IDYA IDEAYA BIOSCIENCES INC -- $73,411.91 3,949 BK0VHF6
0.12% MNKD MANNKIND CORP -- $71,624.85 13,695 BF081J4
0.11% WVE WAVE LIFE SCIENCES LTD -- $69,281.60 6,880 BYZG9R0
0.11% CNTA CENTESSA PHARMACEUTICALS-ADR -- $68,482.34 4,118 BLB0YQ9
0.11% ANIP ANI PHARMACEUTICALS INC -- $64,792.36 982 BCDWBX6
0.10% DYN DYNE THERAPEUTICS INC -- $63,226.17 5,103 BN15WD1
0.10% AMPH AMPHASTAR PHARMACEUTICALS IN -- $61,729.74 2,169 BNFWZS4
0.10% ETNB 89BIO INC -- $60,261.90 6,586 BK1K484
0.09% ADPT ADAPTIVE BIOTECHNOLOGIES -- $57,658.28 6,658 BJ5FZ74
0.09% GPCR STRUCTURE THERAPEUTICS INC -- $56,582.40 2,688 BQS9486
0.09% INDV INDIVIOR PLC -- $56,560.00 5,600 BP0BQQ5
0.09% SPRY ARS PHARMACEUTICALS INC -- $56,509.76 4,384 BMCR7V2
0.09% ARDX ARDELYX INC -- $56,453.25 10,753 BN89V40
0.09% NVAX NOVAVAX INC -- $55,798.64 7,256 BJDQXG4
0.09% OCUL OCULAR THERAPEUTIX INC -- $54,041.04 7,092 BNZB1X8
0.09% IOVA IOVANCE BIOTHERAPEUTICS INC -- $53,691.33 14,791 BF0DMK7
0.09% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $52,966.68 1,787 BLCD809
0.09% SNDX SYNDAX PHARMACEUTICALS INC -- $52,874.23 3,851 BN7Q7R7
0.09% AUPH AURINIA PHARMACEUTICALS INC -- $52,851.88 6,196 BFWLC09
0.09% PCRX PACIRA BIOSCIENCES INC -- $51,865.92 2,088 B3X26D8
0.08% SYRE SPYRE THERAPEUTICS INC -- $51,696.36 2,718 BQBBDY8
0.08% TXG 10X GENOMICS INC-CLASS A -- $50,734.37 4,883 BKS3RS7
0.08% GERN GERON CORP -- $50,281.00 28,732 2370381
0.08% ELVN ENLIVEN THERAPEUTICS INC -- $49,501.84 2,204 BMFD115
0.08% INVA INNOVIVA INC -- $48,991.91 2,827 BDDXF67
0.08% GRAL GRAIL INC -- $48,709.08 1,516 BSLSSX7
0.08% HROW HARROW INC -- $48,210.00 1,607 BHNDW86
0.08% NRIX NURIX THERAPEUTICS INC -- $45,662.82 3,423 BMVLGP2
0.07% VIR VIR BIOTECHNOLOGY INC -- $44,546.40 6,187 BK4PZ38
0.07% KNSA KINIKSA PHARMACEUTICALS INTE -- $44,361.95 1,895 BRXB0C0
0.07% NTLA INTELLIA THERAPEUTICS INC -- $43,477.70 4,670 BYZM6C2
0.07% COLL COLLEGIUM PHARMACEUTICAL INC -- $43,395.20 1,420 BX7RSN3
0.07% GRFS GRIFOLS SA-ADR -- $42,648.25 5,503 B8K7T65
0.07% RCKT ROCKET PHARMACEUTICALS INC -- $41,991.30 4,810 BDFKQ07
0.07% XNCR XENCOR INC -- $41,168.05 3,179 BGCYWN8
0.07% ZYME ZYMEWORKS INC -- $40,546.35 3,107 BPCQZY9
0.06% XERS XERIS BIOPHARMA HOLDINGS INC -- $39,475.75 6,725 BLR7H87
0.06% REPL REPLIMUNE GROUP INC -- $38,387.70 3,474 BDDVW37
0.06% FTRE FORTREA HOLDINGS INC -- $38,041.80 4,047 BRXYZ57
0.06% COGT COGENT BIOSCIENCES INC -- $38,006.40 5,136 BLR6XK8
0.06% DAWN DAY ONE BIOPHARMACEUTICALS I -- $37,993.32 4,572 BLB0YH0
0.06% EOLS EVOLUS INC -- $37,141.00 2,857 BDRJH21
0.06% AVDL AVADEL PHARMACEUTICALS -- $37,079.91 4,347 BDGMC59
0.06% AVXL ANAVEX LIFE SCIENCES CORP -- $36,873.57 3,837 BYTYP72
0.06% GMAB GENMAB A/S -SP ADR -- $36,496.68 1,892 BBC9WC7
0.06% MLYS MINERALYS THERAPEUTICS INC -- $36,350.16 2,248 BP9N0G0
0.06% QURE UNIQURE NV -- $36,024.03 2,439 BJFSR88
0.06% ABCL ABCELLERA BIOLOGICS INC -- $34,817.37 13,443 BL53SR3
0.06% PRAX PRAXIS PRECISION MEDICINES I -- $34,316.10 910 BQ721R4
0.05% LENZ LENZ THERAPEUTICS INC -- $33,085.06 1,241 BQV0J03
0.05% PRTA PROTHENA CORP PLC -- $32,389.52 2,428 B91XRN2
0.05% AVBP ARRIVENT BIOPHARMA INC -- $30,719.20 1,520 BMGTLY5
0.05% CVAC CUREVAC NV -- $30,360.00 10,120 BN4RD42
0.05% CRMD CORMEDIX INC -- $29,477.49 2,737 BJ0LT31
0.05% ABUS ARBUTUS BIOPHARMA CORP -- $28,977.72 8,548 BZ0QMB7
0.05% KURA KURA ONCOLOGY INC -- $27,868.95 3,643 BYZD465
0.04% KALV KALVISTA PHARMACEUTICALS INC -- $27,305.25 2,229 BD06CS0
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $27,114.94 3,526 BFYQFJ2
0.04% CSTL CASTLE BIOSCIENCES INC -- $26,980.28 1,286 BKLCWZ3
0.04% ARVN ARVINAS INC -- $26,708.22 3,102 BDZ30Q0
0.04% ANAB ANAPTYSBIO INC -- $25,875.93 1,383 BDRW1L7
0.04% TRVI TREVI THERAPEUTICS INC -- $25,798.40 4,031 BJH9ZN0
0.04% SANA SANA BIOTECHNOLOGY INC -- $24,374.24 10,072 BMFJJ97
0.04% TYRA TYRA BIOSCIENCES INC -- $24,313.95 2,283 BMVNDH9
0.04% PGEN PRECIGEN INC -- $24,045.84 13,212 BKM5C84
0.04% RLAY RELAY THERAPEUTICS INC -- $23,705.70 7,647 BN2R582
0.04% ORIC ORIC PHARMACEUTICALS INC -- $23,613.48 3,204 BKVDFF7
0.04% OMER OMEROS CORP -- $23,578.28 2,614 B4NB858
0.04% VERV VERVE THERAPEUTICS INC -- $23,154.68 4,006 BNKGXX2
0.04% MNMD MIND MEDICINE MINDMED INC -- $22,891.36 3,308 BPQYY97
0.04% SAGE SAGE THERAPEUTICS INC -- $22,774.54 2,774 BP4GNK9
0.04% URGN UROGEN PHARMA LTD -- $22,657.60 1,904 BZ7PJQ1
0.04% CGEM CULLINAN THERAPEUTICS INC -- $22,545.60 2,640 BM90J52
0.04% MESO MESOBLAST LTD- SPON ADR -- $22,074.26 1,534 BQS7491
0.04% SVRA SAVARA INC -- $21,909.86 7,742 BYXGN81
0.03% HCM HUTCHMED CHINA-ADR -- $21,110.91 1,399 BYXV9H7
0.03% ALT ALTIMMUNE INC -- $21,017.70 3,474 BFY7DC4
0.03% KROS KEROS THERAPEUTICS INC -- $20,944.35 1,830 BM7V485
0.03% ORKA ORUKA THERAPEUTICS INC -- $20,876.04 1,689 BKVF0J2
0.03% TBPH THERAVANCE BIOPHARMA INC -- $20,827.02 2,218 BMNDK09
0.03% TRML TOURMALINE BIO INC -- $20,374.77 1,157 BQ80NC6
0.03% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $20,229.02 917 BL95N25
0.03% PHAT PHATHOM PHARMACEUTICALS INC -- $20,206.75 3,085 BJLKVS6
0.03% STOK STOKE THERAPEUTICS INC -- $19,804.81 2,389 BJQ05Z6
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $19,769.68 2,408 BLFBZ32
0.03% EYPT EYEPOINT PHARMACEUTICALS INC -- $19,520.86 3,079 BMGS7L1
0.03% RGNX REGENXBIO INC -- $19,444.50 2,235 BZ0G875
0.03% HUMA HUMACYTE INC -- $19,269.28 5,804 BMYTJP4
0.03% SIGA SIGA TECHNOLOGIES INC -- $19,261.58 3,221 2107437
0.03% ERAS ERASCA INC -- $19,003.46 12,754 BNLYBF3
0.03% TRDA ENTRADA THERAPEUTICS INC -- $18,316.80 1,696 BP81RK8
0.03% RNAC CARTESIAN THERAPEUTICS INC -- $18,283.18 1,147 BQB9HM8
0.03% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $18,280.40 1,987 BKDQKM6
0.03% GLPG GALAPAGOS NV-SPON ADR -- $17,101.05 659 B292NQ7
0.03% RAPP RAPPORT THERAPEUTICS INC -- $16,863.00 1,650 BR3T9B6
0.03% SLDB SOLID BIOSCIENCES INC -- $16,457.54 3,443 BQHN6C7
0.03% PACB PACIFIC BIOSCIENCES OF CALIF -- $16,430.82 12,354 B4N8MH9
0.03% RIGL RIGEL PHARMACEUTICALS INC -- $16,329.30 795 BQD3J33
0.03% ATXS ASTRIA THERAPEUTICS INC -- $16,218.02 2,546 BMYRFN8
0.03% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $16,215.94 1,222 BKC9SX3
0.03% GLUE MONTE ROSA THERAPEUTICS INC -- $16,160.76 2,772 BP7KZP7
0.03% ABSI ABSCI CORP -- $16,061.10 5,181 BN94K69
0.03% ALLO ALLOGENE THERAPEUTICS INC -- $15,891.12 9,459 BFZNYB7
0.03% AURA AURA BIOSCIENCES INC -- $15,771.00 2,253 BP81R42
0.03% ESPR ESPERION THERAPEUTICS INC -- $15,466.86 8,889 BBNBTD2
0.03% AUTL AUTOLUS THERAPEUTICS PLC -- $15,460.11 9,041 BFMLGR4
0.03% TSHA TAYSHA GENE THERAPIES INC -- $15,351.68 9,248 BNC1BX1
0.03% TKNO ALPHA TEKNOVA INC -- $15,319.85 2,405 BP7L561
0.03% PSNL PERSONALIS INC -- $15,290.88 3,982 BJQ0608
0.02% MXCT MAXCYTE INC -- $14,987.70 4,758 BKMQF66
0.02% AMLX AMYLYX PHARMACEUTICALS INC -- $14,613.48 3,866 BPCK358
0.02% OLMA OLEMA PHARMACEUTICALS INC -- $14,467.68 3,349 BMZ4LN0
0.02% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $14,333.76 6,399 BMCWKZ2
0.02% TECX TECTONIC THERAPEUTIC INC -- $14,252.40 666 BPBPCG8
0.02% OABI OMNIAB INC -- $13,865.86 5,459 BN13S71
0.02% TERN TERNS PHARMACEUTICALS INC -- $13,450.32 3,832 BMDJ0C9
0.02% AQST AQUESTIVE THERAPEUTICS INC -- $13,367.25 4,113 BYVQJ96
0.02% ANNX ANNEXON INC -- $12,984.30 4,809 BMVV9R5
0.02% VNDA VANDA PHARMACEUTICALS INC -- $12,681.42 2,631 B12W3P6
0.02% DSGN DESIGN THERAPEUTICS INC -- $12,591.22 2,554 BMFK3H6
0.02% CRVS CORVUS PHARMACEUTICALS INC -- $12,320.75 2,899 BYP80F1
0.02% AVIR ATEA PHARMACEUTICALS INC -- $12,192.00 3,810 BLN9Z50
0.02% PRME PRIME MEDICINE INC -- $12,011.51 5,917 BPBJFM7
0.02% SLRN ACELYRIN INC -- $11,993.52 4,543 BQPF874
0.02% TSVT 2SEVENTY BIO INC -- $11,541.92 2,327 BMTXV88
0.02% CDXS CODEXIS INC -- $11,472.59 3,737 B5LL2C2
0.02% ITOS ITEOS THERAPEUTICS INC -- $11,354.72 1,648 BMWXFT4
0.02% IRWD IRONWOOD PHARMACEUTICALS INC -- $10,756.31 7,219 B3MZ6K5
0.02% FHTX FOGHORN THERAPEUTICS INC -- $10,587.98 2,509 BMF7DT9
0.02% YMAB Y-MABS THERAPEUTICS INC -- $10,428.36 2,021 BG31GH0
0.02% TVGN TEVOGEN BIO HOLDINGS INC -- $9,792.28 7,897 BPG5P75
0.02% VYGR VOYAGER THERAPEUTICS INC -- $9,634.24 2,464 BY7RB53
0.02% INBX INHIBRX BIOSCIENCES INC -- $9,612.16 653 BNSP8K3
0.02% ACIU AC IMMUNE SA -- $9,457.32 4,461 BZC0D70
0.02% NGNE NEUROGENE INC -- $9,353.20 670 BS2F741
0.01% NMRA NEUMORA THERAPEUTICS INC -- $8,745.60 7,288 BN4JN37
0.01% CRGX CARGO THERAPEUTICS INC -- $8,719.20 2,076 BQHN2F2
0.01% CMPS COMPASS PATHWAYS PLC -- $8,711.11 2,801 BMC3HS7
0.01% TNGX TANGO THERAPEUTICS INC -- $8,485.98 4,877 BP2P6L0
0.01% AMRN AMARIN CORP PLC -ADR -- $8,391.19 18,065 2301938
0.01% FDMT 4D MOLECULAR THERAPEUTICS IN -- $8,209.77 2,089 BKLXFX5
0.01% ALMS ALUMIS INC -- $8,040.75 2,130 BPLQG36
0.01% ACRV ACRIVON THERAPEUTICS INC -- $7,882.05 1,405 BP2TPK4
0.01% SLN SILENCE THERAPEUTICS PLC-ADR -- $7,402.29 2,121 BL5B6Z1
0.01% LYEL LYELL IMMUNOPHARMA INC -- $7,370.26 13,180 BN6MB18
0.01% THRD THIRD HARMONIC BIO INC -- $7,359.46 2,033 BNNPQY8
0.01% CCCC C4 THERAPEUTICS INC -- $7,108.44 3,202 BKX9NQ0
0.01% SCPH SCPHARMACEUTICALS INC -- $7,064.41 2,257 BYX2Z16
0.01% LRMR LARIMAR THERAPEUTICS INC -- $6,561.84 2,878 BMXNGZ6
0.01% ALEC ALECTOR INC -- $6,123.90 4,470 BJ4LDC4
0.01% LXEO LEXEO THERAPEUTICS INC -- $6,102.28 1,492 BQ6C357
0.01% ENTA ENANTA PHARMACEUTICALS INC -- $5,964.40 962 B9L5200
0.01% LXRX LEXICON PHARMACEUTICALS INC -- $5,958.58 16,307 BWFZX59
0.01% MGNX MACROGENICS INC -- $5,548.76 2,831 BFDV8K0
0.01% EDIT EDITAS MEDICINE INC -- $5,176.36 3,724 BZ8FPH3
0.01% NKTX NKARTA INC -- $4,933.65 3,183 BK80YJ8
0.01% FATE FATE THERAPEUTICS INC -- $4,833.83 5,138 BCZS820
0.01% KYTX KYVERNA THERAPEUTICS INC -- $4,577.80 1,948 BSMLR16
0.01% BMEA BIOMEA FUSION INC -- $4,561.65 1,635 BNKF6N0
0.01% PLRX PLIANT THERAPEUTICS INC -- $4,364.55 2,745 BMDWW66
0.01% ARTV ARTIVA BIOTHERAPEUTICS INC -- $4,285.36 1,096 BMF1LJ7
0.01% CLYM CLIMB BIO INC -- $4,003.56 3,033 BMW5LX6
0.01% TCRX TSCAN THERAPEUTICS INC -- $3,544.00 2,215 BNLYBJ7
0.01% PYXS PYXIS ONCOLOGY INC -- $3,219.60 2,683 BLBR8D5
-- APLT APPLIED THERAPEUTICS INC -- $2,937.87 5,249 BJL38Z1
-- INZY INOZYME PHARMA INC -- $2,926.98 2,898 BMVLGY1
-- STRO SUTRO BIOPHARMA INC -- $2,865.52 3,720 BF12XC2
-- OKUR ONKURE THERAPEUTICS INC-A -- $2,832.16 571 BT7KGT6
-- PEPG PEPGEN INC -- $2,507.50 1,475 BMTX3D7
-- MRSN MERSANA THERAPEUTICS INC -- $2,478.87 5,573 BF3NP05
-- IGMS IGM BIOSCIENCES INC -- $1,936.62 1,537 BKS3SM8
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $1,761.30 9,785 BM9HFX3
-- QTTB Q32 BIO INC -- $1,196.82 549 BS2FKQ4
41.87% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 25,468,415 -- 5,660 --
35.63% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 21,670,652 -- 4,816 --
21.71% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 13,202,178 -- 2,934 --
9.77% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 5,944,130 -- 1,321 --
9.30% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 5,656,148 -- 1,257 --
7.03% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 4,274,734 -- 950 --
-- -- TREASURY BILL -- $9,991,852.80 10,000,000 BTBKBR5
-- -- NET OTHER ASSETS (LIABILITIES) -- $5,803,497.75 5,803,498 --

Index

as of 12/31/2024

  • Total Number of Companies265
  • Price/Earnings Ratio--
  • Price/Book Ratio4.157
  • Dividend Yield ( % )0.88
  • Avg. Index Market Capitalization$5.58 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.